Inotech Labor AG in Liq.
Company Overview
Previous Company Names
- Inotech Labor AG
Management
Matthias Häuptli
Basel
Liquidator
Individual signing authority
Walter Dettling
Huningue, FR
Liquidator
Individual signing authority
Jürg Meier
Innsbruck, AT
Liquidator
Individual signing authority
Othmar Kuhn
Thalwil
Delegate
Joint signing authority (any two to sign)
Werner Fischer
Dottikon
President
Joint signing authority (any two to sign)
Dr. Othmar Kuhn
Villmergen
Delegate
Joint signing authority (any two to sign)
Christoph Heinzen
Boniswil
Joint signing authority (any two to sign)
Daniel Jordan
Buschwiller (FR)
Joint signing authority (any two to sign)
Guido Fischer
Boniswil
President
Joint signing authority (any two to sign)
Walter Dettling
Oltingue
President
Individual signing authority
Heinz Bader
Pfeffingen
Member
Individual signing authority
Etienne Bernath
Zollikon
Member
Joint signing authority (any two to sign)
Christoph Biedermann
Zürich
Member
Joint signing authority (any two to sign)
Markus Rohner
Möhlin
Joint signing authority (any two to sign)
Dr. Windenberger
Hochstatt
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 4434 | 27.07.2011 | 147 | 02.08.2011 | 6279790 |
| 2 | 1150 | 11.02.2010 | 33 | 17.02.2010 | 7/5499644 |
| 3 | 4327 | 26.06.2009 | 125 | 02.07.2009 | 11/5107050 |
| 4 | 6740 | 04.12.2008 | 240 | 10.12.2008 | 7/4773714 |
| 5 | 3835 | 07.07.2008 | 133 | 11.07.2008 | 6/4569286 |
| 6 | 5175 | 13.09.2007 | 181 | 19.09.2007 | 4/4116476 |
| 7 | 3781 | 09.07.2007 | 134 | 13.07.2007 | 5/4023600 |
| 8 | 2863 | 25.05.2007 | 104 | 01.06.2007 | 4/3956062 |
| 9 | 7071 | 20.11.2006 | 229 | 24.11.2006 | 5/3649998 |
| 10 | 1342 | 20.02.2006 | 39 | 24.02.2006 | 5/3258814 |
Company Purpose
Herstellung von und Handel mit Produkten für medizinische und technische Zwecke, insbesondere Reagenzien für die Biochemie, Biotechnologie, Zellbiologie, Immunologie und klinische Chemie. Die Gesellschaft kann sich an andern Unternehmungen beteiligen, Liegenschaften erwerben, verwalten und veräussern sowie Finanzierungen aller Art tätigen, insbesondere Darlehen an Dritte oder an Aktionäre gewähren oder solche sicherstellen.